CNE100002102
CNE100002102
WONDFO BIOTECH
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 2.086.830.073 | 3.064.809.397 | 31.9% |
| Cost of Revenue | 897.853.121 | 1.098.880.166 | 18.3% |
| Gross Profit | 1.188.976.952 | 1.965.929.231 | 39.5% |
| 1.286.775.143 | 1.307.995.392 | 1.6% | |
| Operating Income | -97.798.191 | 657.933.839 | 114.9% |
| Pretax Income | -114.693.307 | 629.462.610 | 118.2% |
| Net Income Common Stockholders | -63.024.900 | 561.628.534 | 111.2% |
| -- | -- | -- | |
| -- | -- | -- |